Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TIRAGOLUMAB Cause Chronic obstructive pulmonary disease? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Chronic obstructive pulmonary disease have been filed in association with TIRAGOLUMAB. This represents 0.9% of all adverse event reports for TIRAGOLUMAB.

5
Reports of Chronic obstructive pulmonary disease with TIRAGOLUMAB
0.9%
of all TIRAGOLUMAB reports
1
Deaths
5
Hospitalizations

How Dangerous Is Chronic obstructive pulmonary disease From TIRAGOLUMAB?

Of the 5 reports, 1 (20.0%) resulted in death, 5 (100.0%) required hospitalization.

Is Chronic obstructive pulmonary disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TIRAGOLUMAB. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does TIRAGOLUMAB Cause?

Off label use (58) Hyperthyroidism (39) Pneumonia (29) Pneumonitis (26) Infusion related reaction (23) Intentional product use issue (23) Death (21) Adrenal insufficiency (20) Troponin increased (20) Colitis (15)

What Other Drugs Cause Chronic obstructive pulmonary disease?

ALBUTEROL (2,916) TIOTROPIUM (2,895) BUDESONIDE\FORMOTEROL (2,279) FLUTICASONE\SALMETEROL (1,904) ADALIMUMAB (1,712) PREDNISONE (1,237) FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (1,145) MEPOLIZUMAB (1,107) FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (967) DUPILUMAB (907)

Which TIRAGOLUMAB Alternatives Have Lower Chronic obstructive pulmonary disease Risk?

TIRAGOLUMAB vs TIRBANIBULIN TIRAGOLUMAB vs TIRZEPATIDE TIRAGOLUMAB vs TISLELIZUMAB TIRAGOLUMAB vs TISOTUMAB VEDOTIN TIRAGOLUMAB vs TISOTUMAB VEDOTIN-TFTV

Related Pages

TIRAGOLUMAB Full Profile All Chronic obstructive pulmonary disease Reports All Drugs Causing Chronic obstructive pulmonary disease TIRAGOLUMAB Demographics